Murine recombinant leukemia inhibitory factor modulates inhibitory effect of 1,25 dihydroxyvitamin D3 on alkaline phosphatase activity in MC3T3-E1 cells
โ Scribed by Yoshiyuki Hakeda; Tetsuo Sudo; Seiichi Ishizuka; Kayo Tanaka; Kiyoshi Higashino; Michinori Kusuda; Hiroaki Kodama; Masayoshi Kumegawa
- Book ID
- 115764428
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 403 KB
- Volume
- 175
- Category
- Article
- ISSN
- 0006-291X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
High homocysteine (HCY) levels are a risk factor for osteoporotic fracture. Furthermore, bone quality and strength are compromised by elevated HCY owing to its negative impact on collagen maturation. HCY is cleared by cystathionine b-synthase (CBS), the first enzyme in the transsulfuration pathway.
Treatment of rheumatoid arthritis (RA) with cyclosporin A (CsA) has been successful, but the adverse effects of the drug have limited its use. We investigated the capacity of another immunosuppressive agent, 1,25dihydroxyvitamin D, [1,25(OH),D,], to augment the effect of CsA on in vitro T cell funct